Novavax | NVAX - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Adma Biologics USD 20.52M 2M 2026-03
Agenus USD 71.08M 11.9M 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
Cassava Sciences USD 41.65M 4.44M 2025-12
Geron USD 12.72M 1.46M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
MannKind USD 16.14M 7.11M 2026-03
Merck USD 3.86B 541M 2026-03
Minerva Neurosciences USD 640K 305K 2025-12
Moderna USD 161M 156M 2026-03
Novartis USD 4.46B 99M 2025-12
Novavax USD 16.1M 8.48M 2026-03
Pfizer USD 4.51B 734M 2026-03
Sanofi EUR 22.71B 219M 2026-03
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
TG Therapeutics USD 148.84M 41.34M 2026-03